Peptide Science Desk

Compounded vs. FDA-Approved Peptides: What the Difference Means

Published 2026-10-16 · Peptide Science Desk Editorial Team

Pending medical review. This article has not yet been reviewed by a licensed clinician. It summarizes regulatory documents and does not provide dosing or treatment guidance. See our Editorial Policy.

The word “peptide” covers both FDA-approved medicines and compounded or unapproved products. This page summarizes what FDA says about the difference. The main source is FDA’s Compounding and the FDA: Questions and Answers.

Compounded drugs are not FDA-approved

FDA states: “Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” FDA also notes that compounded drugs are not generics, which are approved under section 505(j).

When FDA says compounding is appropriate

FDA describes compounding for patients who cannot be treated with an FDA-approved medication. One example is a patient allergic to a dye. FDA says compounded drugs “should only be used in patients whose medical needs cannot be met by an FDA-approved drug,” and that poor compounding practices can cause contamination or wrong strength.

503A pharmacies vs. 503B outsourcing facilities

503A (state-licensed pharmacy/physician)503B (outsourcing facility)
Primary oversightState boards of pharmacy (FDA can do surveillance and for-cause inspections)FDA, risk-based inspection schedule
CGMP requirementsNot subject to CGMPSubject to CGMP
Created byFD&C Act section 503ADrug Quality and Security Act (2013)

Source: FDA Q&A.

Which bulk substances a 503A pharmacy may use is a separate question. See our 503A bulks explainer.

Biologics cannot be compounded

FDA states that biological products “are not eligible for the exemptions for compounded drugs under sections 503A and 503B.”

Buying compounded drugs online

FDA says consumers buying compounded drugs through online pharmacies or telehealth platforms “may not know the identity of the compounder.” FDA encourages consumers to research the pharmacy and to talk to a healthcare provider, and it points to BeSafeRx.

Limits of this summary

This page explains regulatory categories. It is not a recommendation to use any product.